IBDEI0AD ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4465,1,4,0)
 ;;=4^531.90
 ;;^UTILITY(U,$J,358.3,4465,1,5,0)
 ;;=5^Gastric Ulcer,Unspec
 ;;^UTILITY(U,$J,358.3,4465,2)
 ;;=^51128
 ;;^UTILITY(U,$J,358.3,4466,0)
 ;;=531.91^^23^230^17
 ;;^UTILITY(U,$J,358.3,4466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4466,1,4,0)
 ;;=4^531.91
 ;;^UTILITY(U,$J,358.3,4466,1,5,0)
 ;;=5^Gastric Ulcer w/ Obstruction
 ;;^UTILITY(U,$J,358.3,4466,2)
 ;;=^270088
 ;;^UTILITY(U,$J,358.3,4467,0)
 ;;=789.51^^23^230^25
 ;;^UTILITY(U,$J,358.3,4467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4467,1,4,0)
 ;;=4^789.51
 ;;^UTILITY(U,$J,358.3,4467,1,5,0)
 ;;=5^Malignant Ascites
 ;;^UTILITY(U,$J,358.3,4467,2)
 ;;=^335281
 ;;^UTILITY(U,$J,358.3,4468,0)
 ;;=533.90^^23^230^29
 ;;^UTILITY(U,$J,358.3,4468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4468,1,4,0)
 ;;=4^533.90
 ;;^UTILITY(U,$J,358.3,4468,1,5,0)
 ;;=5^Peptic Ulcer w/o Obstruc
 ;;^UTILITY(U,$J,358.3,4468,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,4469,0)
 ;;=533.91^^23^230^28
 ;;^UTILITY(U,$J,358.3,4469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4469,1,4,0)
 ;;=4^533.91
 ;;^UTILITY(U,$J,358.3,4469,1,5,0)
 ;;=5^Peptic Ulcer w/ Obstruction
 ;;^UTILITY(U,$J,358.3,4469,2)
 ;;=^270138
 ;;^UTILITY(U,$J,358.3,4470,0)
 ;;=070.54^^23^230^7
 ;;^UTILITY(U,$J,358.3,4470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4470,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,4470,1,5,0)
 ;;=5^Chr Hep C w/o Coma
 ;;^UTILITY(U,$J,358.3,4470,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,4471,0)
 ;;=V02.62^^23^230^21
 ;;^UTILITY(U,$J,358.3,4471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4471,1,4,0)
 ;;=4^V02.62
 ;;^UTILITY(U,$J,358.3,4471,1,5,0)
 ;;=5^Hepatitis C Carrier
 ;;^UTILITY(U,$J,358.3,4471,2)
 ;;=^317947
 ;;^UTILITY(U,$J,358.3,4472,0)
 ;;=583.9^^23^231^7
 ;;^UTILITY(U,$J,358.3,4472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4472,1,4,0)
 ;;=4^583.9
 ;;^UTILITY(U,$J,358.3,4472,1,5,0)
 ;;=5^Glomerulonephritis
 ;;^UTILITY(U,$J,358.3,4472,2)
 ;;=^83446
 ;;^UTILITY(U,$J,358.3,4473,0)
 ;;=581.9^^23^231^9
 ;;^UTILITY(U,$J,358.3,4473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4473,1,4,0)
 ;;=4^581.9
 ;;^UTILITY(U,$J,358.3,4473,1,5,0)
 ;;=5^Nephrotic Syndrome
 ;;^UTILITY(U,$J,358.3,4473,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,4474,0)
 ;;=753.12^^23^231^13
 ;;^UTILITY(U,$J,358.3,4474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4474,1,4,0)
 ;;=4^753.12
 ;;^UTILITY(U,$J,358.3,4474,1,5,0)
 ;;=5^Polycystic Kidney Disease
 ;;^UTILITY(U,$J,358.3,4474,2)
 ;;=^67295
 ;;^UTILITY(U,$J,358.3,4475,0)
 ;;=596.0^^23^231^3
 ;;^UTILITY(U,$J,358.3,4475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4475,1,4,0)
 ;;=4^596.0
 ;;^UTILITY(U,$J,358.3,4475,1,5,0)
 ;;=5^Bladder Neck Obstruction
 ;;^UTILITY(U,$J,358.3,4475,2)
 ;;=^15144
 ;;^UTILITY(U,$J,358.3,4476,0)
 ;;=788.1^^23^231^5
 ;;^UTILITY(U,$J,358.3,4476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4476,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,4476,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,4476,2)
 ;;=^37716
 ;;^UTILITY(U,$J,358.3,4477,0)
 ;;=604.90^^23^231^12
 ;;^UTILITY(U,$J,358.3,4477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4477,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,4477,1,5,0)
 ;;=5^Orchitis/Epididymit
 ;;^UTILITY(U,$J,358.3,4477,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,4478,0)
 ;;=788.30^^23^231^18
 ;;^UTILITY(U,$J,358.3,4478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4478,1,4,0)
 ;;=4^788.30
 ;;^UTILITY(U,$J,358.3,4478,1,5,0)
 ;;=5^Urinary Incontinence,Unspec
 ;;^UTILITY(U,$J,358.3,4478,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,4479,0)
 ;;=596.54^^23^231^10
 ;;
 ;;$END ROU IBDEI0AD
